
David K. O. Dell
Examiner (ID: 15868, Phone: (571)272-9071 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1609, 1625, 1621 |
| Total Applications | 1704 |
| Issued Applications | 862 |
| Pending Applications | 109 |
| Abandoned Applications | 750 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19497611
[patent_doc_number] => 20240336629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => Tricyclic Derivatives Useful As PARP7 Inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/276269
[patent_app_country] => US
[patent_app_date] => 2022-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68841
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18276269
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/276269 | Tricyclic Derivatives Useful As PARP7 Inhibitors | Jan 25, 2022 | Pending |
Array
(
[id] => 19127087
[patent_doc_number] => 20240132440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => METHOD FOR THE PRODUCTION OF D-ERYTHRO-SPHINGOSINE AND ANALOGS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/262913
[patent_app_country] => US
[patent_app_date] => 2022-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17905
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18262913
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/262913 | METHOD FOR THE PRODUCTION OF D-ERYTHRO-SPHINGOSINE AND ANALOGS THEREOF | Jan 24, 2022 | Pending |
Array
(
[id] => 17595292
[patent_doc_number] => 20220144865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => IMIDAZOQUINOLINE DERIVATIVES AND THEIR USE IN THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/582150
[patent_app_country] => US
[patent_app_date] => 2022-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10087
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17582150
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/582150 | IMIDAZOQUINOLINE DERIVATIVES AND THEIR USE IN THERAPY | Jan 23, 2022 | Abandoned |
Array
(
[id] => 17595260
[patent_doc_number] => 20220144833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => IMIDAZOQUINOLINE DERIVATIVES AND THEIR USE IN THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/582176
[patent_app_country] => US
[patent_app_date] => 2022-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10082
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17582176
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/582176 | IMIDAZOQUINOLINE DERIVATIVES AND THEIR USE IN THERAPY | Jan 23, 2022 | Abandoned |
Array
(
[id] => 19060125
[patent_doc_number] => 11939333
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 17/578309
[patent_app_country] => US
[patent_app_date] => 2022-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 37
[patent_no_of_words] => 117594
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17578309
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/578309 | Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same | Jan 17, 2022 | Issued |
Array
(
[id] => 17975517
[patent_doc_number] => 11492365
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Heterocyclic GLP-1 agonists
[patent_app_type] => utility
[patent_app_number] => 17/571351
[patent_app_country] => US
[patent_app_date] => 2022-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39575
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17571351
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/571351 | Heterocyclic GLP-1 agonists | Jan 6, 2022 | Issued |
Array
(
[id] => 17563078
[patent_doc_number] => 20220127227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides
[patent_app_type] => utility
[patent_app_number] => 17/568824
[patent_app_country] => US
[patent_app_date] => 2022-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 102629
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17568824
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/568824 | Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides | Jan 4, 2022 | Issued |
Array
(
[id] => 17776466
[patent_doc_number] => 20220242815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => COMPOSITIONS AND METHODS RELATED TO DI-SUBSTITUTED BICYCLO[2.2.1] HEPTANAMINE-CONTAINING COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/560997
[patent_app_country] => US
[patent_app_date] => 2021-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47629
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17560997
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/560997 | Compositions and methods related to di-substituted bicyclo[2.2.1] heptanamine-containing compounds | Dec 22, 2021 | Issued |
Array
(
[id] => 18283731
[patent_doc_number] => 20230099203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => 6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/559051
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 158409
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17559051
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/559051 | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors | Dec 21, 2021 | Issued |
Array
(
[id] => 20671920
[patent_doc_number] => 12612420
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-28
[patent_title] => Arginase inhibitors and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/558841
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25323
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17558841
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/558841 | Arginase inhibitors and methods of use thereof | Dec 21, 2021 | Issued |
Array
(
[id] => 17704470
[patent_doc_number] => 20220204476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => RNA VIRUS INHIBITOR COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/556700
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46796
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556700
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/556700 | RNA VIRUS INHIBITOR COMPOUNDS AND USES THEREOF | Dec 19, 2021 | Abandoned |
Array
(
[id] => 19536721
[patent_doc_number] => 12129262
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-29
[patent_title] => CDK inhibitors and their use as pharmaceuticals
[patent_app_type] => utility
[patent_app_number] => 17/554284
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44035
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554284
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554284 | CDK inhibitors and their use as pharmaceuticals | Dec 16, 2021 | Issued |
Array
(
[id] => 19127097
[patent_doc_number] => 20240132450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88
[patent_app_type] => utility
[patent_app_number] => 18/257773
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33157
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18257773
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/257773 | MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 | Dec 16, 2021 | Pending |
Array
(
[id] => 18964140
[patent_doc_number] => 11897890
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => 2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/547983
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 11
[patent_no_of_words] => 27552
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17547983
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/547983 | 2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof | Dec 9, 2021 | Issued |
Array
(
[id] => 18270985
[patent_doc_number] => 20230092227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => PREPARATION METHOD FOR SYNTHESIZING CHIRAL NICOTINE FROM CHIRAL TERT-BUTYLSULFENAMIDE
[patent_app_type] => utility
[patent_app_number] => 17/547242
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2977
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17547242
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/547242 | PREPARATION METHOD FOR SYNTHESIZING CHIRAL NICOTINE FROM CHIRAL TERT-BUTYLSULFENAMIDE | Dec 9, 2021 | Abandoned |
Array
(
[id] => 19904098
[patent_doc_number] => 12281094
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-22
[patent_title] => Preparation method of racemic nicotine
[patent_app_type] => utility
[patent_app_number] => 17/547254
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17547254
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/547254 | Preparation method of racemic nicotine | Dec 9, 2021 | Issued |
Array
(
[id] => 19127131
[patent_doc_number] => 20240132484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => BROAD SPECTRUM ANTIVIRAL COMPOUNDS TARGETING THE SKI COMPLEX
[patent_app_type] => utility
[patent_app_number] => 18/265191
[patent_app_country] => US
[patent_app_date] => 2021-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265191
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/265191 | BROAD SPECTRUM ANTIVIRAL COMPOUNDS TARGETING THE SKI COMPLEX | Dec 2, 2021 | Pending |
Array
(
[id] => 18971835
[patent_doc_number] => 20240051927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => FLOW SYNTHESIS OF RDX
[patent_app_type] => utility
[patent_app_number] => 18/256548
[patent_app_country] => US
[patent_app_date] => 2021-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2326
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18256548
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/256548 | FLOW SYNTHESIS OF RDX | Nov 30, 2021 | Pending |
Array
(
[id] => 18920545
[patent_doc_number] => 20240023549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => FUNGICIDAL ARYL AMIDINES
[patent_app_type] => utility
[patent_app_number] => 18/253822
[patent_app_country] => US
[patent_app_date] => 2021-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17616
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18253822
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/253822 | FUNGICIDAL ARYL AMIDINES | Nov 21, 2021 | Abandoned |
Array
(
[id] => 20664779
[patent_doc_number] => 12606541
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-21
[patent_title] => PPARg modulators and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/521666
[patent_app_country] => US
[patent_app_date] => 2021-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 181547
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17521666
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/521666 | PPARg modulators and methods of use | Nov 7, 2021 | Issued |